STAT3 and esophageal adenocarcinoma: Schoppmann et al., examined tumours from 324 patients with OAC and SCC and 45 patients with precursor lesions, and demonstrated that STAT3 played a role in the development of oesophageal adenocarcinoma, however, only the combination with Her-2 expression status was associated with an adverse survival outcome [28].